Should I Buy THC? THC 2026 Analysis

Should You Buy Tenet Healthcare Corp (THC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

188.960

1 Day change

-0.28%

52 Week Range

222.810

Analysis Updated At

2026/01/26

Tenet Healthcare Corp (THC) is not a strong buy for a beginner investor with a long-term strategy at this moment. The technical indicators suggest a bearish trend, and the financial performance shows declining profitability. While hedge funds are buying, insider selling has significantly increased, which raises concerns. Analyst ratings remain positive overall, but recent price target reductions reflect caution. Given the lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals, it is better to hold off on buying this stock for now.

Technical Analysis

The MACD histogram is negative (-1.302) and expanding, indicating a bearish trend. The RSI is neutral at 25.742, and moving averages are converging, suggesting no clear direction. The stock is trading near its key support level (S1: 187.505), with resistance levels at R1: 203.419 and R2: 208.335. Overall, the technical indicators point to a bearish or neutral trend.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Hedge funds have increased their buying activity by 337.36% over the last quarter. Analysts maintain a generally positive outlook with multiple Buy and Overweight ratings.

Neutral/Negative Catalysts

Insiders have increased selling by 1492.05% over the last month. Financial performance in Q3 2025 shows declining net income (-27.54% YoY) and EPS (-21.06% YoY). The MACD and stock trend analysis suggest a bearish outlook. No recent news or Congress trading data is available to provide additional positive sentiment.

Financial Performance

In Q3 2025, revenue increased by 3.26% YoY to $5.29 billion. However, net income dropped by 27.54% YoY to $342 million, and EPS fell by 21.06% YoY to 3.86. Gross margin slightly declined to 78.28%, down 0.56% YoY, reflecting weakening profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain a positive outlook with Buy and Overweight ratings. However, recent price target adjustments have been mixed, with some firms lowering targets due to potential legislative risks and post-COVID challenges. The current price targets range from $229 to $257, with a general consensus of cautious optimism.

15 Analyst Rating

Wall Street analysts forecast THC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THC is 241.36 USD with a low forecast of 224 USD and a high forecast of 260 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

15 Buy

0 Hold

0 Sell

Strong Buy

Current: 189.490

Low

224

Averages

241.36

High

260

Current: 189.490

Low

224

Averages

241.36

High

260

TD Cowen

Ryan Langston

Buy

maintain

$233 -> $230

AI Analysis

2026-01-07

Reason

TD Cowen

Ryan Langston

Price Target

$233 -> $230

AI Analysis

2026-01-07

maintain

Buy

Reason

TD Cowen analyst Ryan Langston lowered the firm's price target on Tenet Healthcare to $230 from $233 and keeps a Buy rating on the shares. The firm updated its model as they now see a slim chance of an ACA subsidy extension and are now contemplating associated payor mix headwinds.

Wells Fargo

Overweight

downgrade

$252 -> $229

2026-01-07

Reason

Wells Fargo

Price Target

$252 -> $229

2026-01-07

downgrade

Overweight

Reason

Wells Fargo lowered the firm's price target on Tenet Healthcare to $229 from $252 and keeps an Overweight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for THC

Unlock Now

THC Should I Buy

THC Should I Buy

Should You Buy Tenet Healthcare Corp (THC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch